Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Altimmune
ALT
$585M
| $670K | ﹤0.01% |
67,972
+35,127
| +107% | +$480K |
|
|
TSC
2877
DELISTED
TriState Capital Holdings, Inc.
TSC
| $670K | ﹤0.01% |
32,909
-10,475
| -24% | -$239K |
|
2878
Suzano
SUZ
$10.2B
| $669K | ﹤0.01% |
55,530
+2,963
| +6% | +$36.3K |
|
2879
Heron Therapeutics
HRTX
$94.5M
| $666K | ﹤0.01% |
42,919
-95,707
| -69% | -$1.52M |
|
|
CSW
2880
CSW Industrials
CSW
$5.67B
| $665K | ﹤0.01% |
5,606
-7,071
| -56% | -$902K |
|
2881
Invesco CurrencyShares British Pound Sterling Trust
FXB
$64.6M
| $665K | ﹤0.01% |
4,981
| – | – |
|
2882
Silicon Motion
SIMO
$9.07B
| $662K | ﹤0.01% |
10,333
+1,875
| +22% | +$123K |
|
2883
PTC Therapeutics
PTCT
$5.91B
| $661K | ﹤0.01% |
15,638
-70,943
| -82% | -$3.04M |
|
|
AOD
2884
abrdn Total Dynamic Dividend Fund
AOD
$1.12B
| $660K | ﹤0.01% |
59,507
| – | – |
|
2885
CorVel
CRVL
$3.19B
| $657K | ﹤0.01% |
14,664
-18,582
| -56% | -$734K |
|
2886
WisdomTree
WT
$3.26B
| $657K | ﹤0.01% |
106,049
-56,635
| -35% | -$373K |
|
2887
PUT
ProShares Ultra Silver
AGQ
$1.28B
| $655K | ﹤0.01% |
14,200
| – | – |
|
2888
First Community Bankshares
FCBC
$917M
| $655K | ﹤0.01% |
21,962
-12,264
| -36% | -$370K |
|
2889
Comscore
SCOR
$113M
| $655K | ﹤0.01% |
6,545
-2,523
| -28% | -$198K |
|
|
HQH
2890
abrdn Healthcare Investors
HQH
$1.31B
| $654K | ﹤0.01% |
25,127
+6,396
| +34% | +$158K |
|
2891
Schwab US REIT ETF
SCHH
$11.4B
| $653K | ﹤0.01% |
28,516
+26,694
| +1,465% | +$593K |
|
|
SPPI
2892
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $653K | ﹤0.01% |
174,379
-29,694
| -15% | -$103K |
|
|
EBIX
2893
DELISTED
Ebix Inc
EBIX
| $653K | ﹤0.01% |
19,311
-18,843
| -49% | -$583K |
|
2894
WisdomTree India Earnings Fund ETF
EPI
$2.05B
| $652K | ﹤0.01% |
19,289
-13,128
| -40% | -$428K |
|
2895
Safe Bulkers
SB
$781M
| $652K | ﹤0.01% |
162,627
+27,564
| +20% | +$96.5K |
|
|
HMHC
2896
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $651K | ﹤0.01% |
58,988
-83,599
| -59% | -$787K |
|
|
QADA
2897
DELISTED
QAD Inc.
QADA
| $651K | ﹤0.01% |
7,484
-2,325
| -24% | -$170K |
|
|
TGI
2898
DELISTED
Triumph Group
TGI
| $650K | ﹤0.01% |
31,299
-148,022
| -83% | -$2.73M |
|
2899
CALL
Signet Jewelers
SIG
$3.65B
| $646K | ﹤0.01% |
8,000
| – | – |
|
2900
Pegasystems
PEGA
$5.21B
| $644K | ﹤0.01% |
9,244
-12,208
| -57% | -$770K |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.